Piper Sandler Maintains Overweight on MetLife, Lowers Price Target to $82
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst John Barnidge maintains an Overweight rating on MetLife (MET) but lowers the price target from $85 to $82.

May 06, 2024 | 1:22 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Piper Sandler maintains an Overweight rating on MetLife but lowers the price target from $85 to $82.
The adjustment in price target by Piper Sandler suggests a slight moderation in expectations for MetLife's stock performance. However, maintaining an Overweight rating indicates a continued positive outlook on the stock. The reduction in price target might have a neutral to slightly negative short-term impact on investor sentiment, as it reflects a tempered but still positive expectation of the company's future performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100